Dataset Information


Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma.

ABSTRACT: Although there is a relationship between DNA repair deficiency and temozolomide (TMZ) resistance in glioblastoma (GBM), it remains unclear which molecule is associated with GBM recurrence. We isolated three TMZ-resistant human GBM cell lines and examined the expression of O6-methylguanine-DNA methyltransferase (MGMT) and mismatch repair (MMR) components. We used immunohistochemical analysis to compare MutL homolog 1 (MLH1), postmeiotic segregation increased 2 (PMS2) and MGMT expression in primary and recurrent GBM specimens obtained from GBM patients during TMZ treatment. We found a reduction in MLH1 expression and a subsequent reduction in PMS2 protein levels in TMZ-resistant cells. Furthermore, MLH1 or PMS2 knockdown confered TMZ resistance. In recurrent GBM tumours, the expression of MLH1 and PMS2 was reduced when compared to primary tumours.

PROVIDER: S-EPMC3926825 | BioStudies | 2013-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7256087 | BioStudies
1000-01-01 | S-EPMC4061125 | BioStudies
2019-01-01 | S-EPMC6917414 | BioStudies
2018-01-01 | S-EPMC5873285 | BioStudies
2019-01-01 | S-EPMC6732255 | BioStudies
2019-01-01 | S-EPMC6846869 | BioStudies
| S-EPMC4766077 | BioStudies
1999-01-01 | S-EPMC22005 | BioStudies
2018-01-01 | S-EPMC6063898 | BioStudies
2019-01-01 | S-EPMC6618857 | BioStudies